FRIDAY, OCTOBER 31, 2014 

EPIDEMIOLOGY AND RISK FACTOR OF VENOUS THROMBOSIS IN CHILDREN

11:00-13:00
PARALLEL SESSION III: Epidemiology and risk factors of venous thrombosis in children
Chairpersons
U. Nowak-Göttl, Germany
H. Van Ommen, Netherlands
11:00
State of the Art:
Epidemiology and risk factors of venous thromboembolism in children
H. Van OmmenNetherlands
11:20
Debate: Should infants with perinatal thrombosis be screened for thrombophilia and treated by anticoagulants?
Yes: U. Nowak-Göttl, Germany
No: S. Revel-Vilk, Israel
Discussion
12:05
Debate: Is there a role for primary anticoagulant prophylaxis in children with acute lymphocytic leukemia?
Yes: U. Nowak-Göttl, Germany
No: H. Van Ommen, Netherlands
Discussion 
12:50
Oral Presentation:
CLINICAL AND LABORATORY CHARACTERISTICS OF CHILDREN WITH VENOUS THROMBOEMBOLISM AND PROTEIN C-DEFICIENCY: AN OBSERVATIONAL
ISRAELI-GERMAN COHORT STUDY
V. Limperger,
Germany 
13:00
Lunch break and poster viewing

HEMOPHILIA CARE: CURRENT GUIDELINES & APPLICATIONS OF NEW FACTOR CONCENTRATES

14:00-16:00
PARALLEL SESSION IV: Hemophilia care: Current guidelines and applications of new factor concentrates 
Chairpersons
E. Santagostino, Italy
K. Fischer, Netherlands
14:00
State of the Art:
Hemophilia care - current guidelines and applications of new factor concentrates
K. Fischer, Netherlands 
14:20
Debate: Prophylaxis for children with hemophilia should start early or after joint bleed? Is low dose regimen preferable to standard dose?
Early start and frequent dosing: R. Ljung, Sweden
Lower doeses: E. Santagostino, Italy
Discussion 
15:10
Debate: Should we screen children for coagulopathies prior to surgery?
No - not always: C. Bidlingmaier, Germany
Yes - most of the time: S. Revel-Vilk, Israel
Discussion

SATURDAY, NOVEMBER 1, 2014 

HEPARINS, WARFARIN & NEW ANTICOAGULANTS FOR PEDIATRIC VENOUS THROMBOSIS

10:30-12:30
PARALLEL SESSION VIII: Heparins, warfarin and new anticoagulants for pediatric venous thrombosis 
Chairpersons
C. Bidlingmaier, Germany
I. Martinelli, Italy
 10:30
State of the Art:
Heparins and warfarin for pediatric venous thrombosis: Current recommendations
C. BidlingmaierGermany
 10:50
DebateNew oral anticoagulants in children: should they be prescribed for special (off label) situations?
Yes: I. Martinelli, Italy
No: A.D. Michelson, USA
Discussion 
 11:35
Debate: Antiphospholipid syndrome in children - should similar diagnostic criteria be applied?
Yes: V. Pengo, Italy
No: T. Strauss, Israel
Discussion
12:20
Oral Presentation:
IS INHERITED THROMBOPHILIA TESTING JUSTIFIED IN CHILDREN WITH PERINATAL ARTERIAL ISCHEMIC STROKE?

D. Coen Herak,
Croatia 
12:30
Lunch break and poster viewing